Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Coy Heldermon
University of Florida, Department: Md Hematology/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cardinal Health Specialty Solutions
February 1, 2017 Dear Dr. Heldermon: On behalf of Cardinal Health Specialty Solutions, I cordially invite you to attend our 2017 March Oncology Summit, a 2-day advisory program to be held on March 24 and 25, 2017, in Orlando, Florida. As a leader in the oncology community, your knowledge and insights will be valuable to the summit program and to Cardinal Health. The summit will begin on the morning of Friday, March 24th and end in the afternoon on Saturday, March 25th. Meeting venue and overnight accommodations: Hyatt Regency Orlando International Airport 9300 Jeff Fuqua Boulevard Orlando, Florida 32827 (407) 825-1234 Summit objectives: ? Understand the role technology will play in community oncology practices in the next decade. ? Determine how oncology practices are preparing for and implementing USP800 standards and identify key issues that may impact oncology providers. ? Discuss the benefits of data analytics in community oncology practices. ? Gain insight into clinical advances in cancer patient care. To participate as an advisor in the 2017 March Oncology Summit and receive the full honorarium, you will be required to be present, participate, and provide feedback in all Cardinal Health consulting sessions. You will also be required to sign a consulting agreement, which will be sent to you after completing the registration process. In addition to receiving an honorarium of $1,500? based on fair market value for your full participation, you will also receive complimentary air/train fare, reimbursement for out-of-pocket travel-related expenses, and one night of hotel accommodations in Orlando. Please note: Travel arrangements must be booked through our travel agency.* Additional travel details will be sent to you in a confirmation email. To register for this event, please click HERE. If you have any questions, please contact Bill Hogan at 484-288-0366 or [email protected]. Cardinal Health Specialty Solutions and I, as the summit moderator, look forward to working with you. Best Regards, Chadi Nabhan, MD, MBA VP/Chief Medical Officer Cardinal Health Specialty Solutions
one weekday and one weekend day in Orlando
Filed on February 24, 2017.
Tell us what you know about Coy Heldermon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Coy Heldermon”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Coy Heldermon | University of Florida | Conflict of Interest | Lacerta Therapeutics, Inc. | $0 - $4,999 |
| Coy Heldermon | University of Florida | Financial Disclosure | Elite Medical Experts | |
| Coy Heldermon | University of Florida | Financial Disclosure | mallinckrodt ARD Inc. | |
| Coy Heldermon | University of Florida | Financial Disclosure | Geno-immune Medical Institute | |
| Coy Heldermon | University of Florida | Financial Disclosure | Coleman Experts | |
| Coy Heldermon | University of Florida | Financial Disclosure | Guidepoint | |
| Coy Heldermon | University of Florida | Financial Disclosure | Genzyme Corporation (Biomarin-Genzyme) | |
| Coy Heldermon | University of Florida | Conflict of Interest | Lacerta Therapeutics, Inc. | $0 - $4,999 |
| Coy Heldermon | University of Florida | Financial Disclosure | Genzyme Corporation (Biomarin-Genzyme) |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.